Claritas Pharmaceuticals, Inc. (CLAZF)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0001 - Volume
250 - Avg. Volume
0 - Market Cap (intraday)
664,660 - Beta (5Y Monthly) 33.74
- PE Ratio (TTM)
0.00 - EPS (TTM)
0.9000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.
Recent News: CLAZF
View MorePerformance Overview: CLAZF
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLAZF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLAZF
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
2.77%
Return on Equity (ttm)
65.09%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
1.8M
Diluted EPS (ttm)
0.9000
Balance Sheet and Cash Flow
Total Cash (mrq)
2k
Total Debt/Equity (mrq)
16.40%
Levered Free Cash Flow (ttm)
-10.71M